Cybersecurity & Cloud Systems

Cloud-Based Systems for Medical Devices: FDA Perspective

April 22, 2024
|
By Dr. Ebot Eyong

The FDA advocates adopting cloud-based systems for medical devices, highlighting benefits such as scalability, enhanced security, collaboration, innovation potential, and operational cost savings. This article explains FDA perspectives and best practices for cloud-based medical device systems.

Overview

The FDA advocates adopting cloud-based systems for medical devices, highlighting key benefits such as scalability, enhanced security, and innovation potential. Utilizing cloud solutions can improve patient care, simplify regulatory compliance, and help reduce operational expenses.

Advantages of Cloud-Based Systems in Medical Devices

  • Scalability and Flexibility: Cloud solutions are designed to manage large volumes of data and can scale resources as necessary, adapting to the evolving needs of healthcare organizations.
  • Enhanced Security: Cloud platforms incorporate security measures like encryption and access controls to protect sensitive patient and device data.
  • Improved Collaboration: These systems facilitate seamless data sharing among healthcare professionals, enabling better coordination and decision-making.
  • Cost Savings: By reducing the need for on-premises infrastructure and ongoing maintenance, cloud solutions help organizations save money.

FDA Guidance on Cloud-Based Medical Devices

  • Premarket Cybersecurity Guidance: The FDA emphasizes cybersecurity throughout the design phase of medical devices, especially those that use cloud-based systems.
  • Post-Market Surveillance: Manufacturers are required to monitor and report cybersecurity vulnerabilities and incidents related to their devices after they have reached the market.

Best Practices for Implementing Cloud-Based Medical Devices

  • Choose a Secure Cloud Platform: Select a cloud platform that complies with FDA regulations and offers robust security features.
  • Implement Cybersecurity Measures: Ensure that cloud-based systems incorporate adequate protection mechanisms, such as encryption and access controls.
  • Perform Regular Security Audits: Conduct consistent reviews of cloud-based systems to identify and address potential security vulnerabilities.

For more information, visit https://eemedicals.com/

Explore More Publications

Continue exploring Dr. Ebot Eyong’s professional insights on healthcare regulation, FDA submissions, AI-enabled medical devices, quality systems, and global compliance strategy.

CMC & FDA Submissions

FDA 510(k) Regulatory Strategy & Predicate Assessment. How E&E Medicals Guided an Innovative Orthopedic Device Manufacturer from Regulatory Uncertainty to FDA Clearance

August 7, 2026
|
Dr. Ebot Eyong, PhD, CQE, RAC.

E&E Medicals combined expertise in FDA regulations, quality management systems, risk management, engineering documentation, software compliance, and commercialization planning to guide the client from uncertainty to confidence.

Read Article

Software & SaMD

The Hidden Risk: Gaps in Software Remediation for Medical Devices

June 10, 2025
|
By Dr. Ebot Eyong

As medical devices evolve into software-driven, connected systems, software remediation has become a critical driver of patient safety, regulatory compliance, and commercial success. Yet current frameworks remain fragmented, reactive, and poorly integrated, creating systemic risk and a major opportunity to build regulatory-aware software infrastructure.

Read Article

Global Regulatory Strategy

One Medical Device, Multiple Regulatory Frameworks

August 10, 2024
|
By Dr. Ebot Eyong

A medical device may be engineered to a single design specification and validated to the same performance standards globally, but its regulatory pathway varies significantly depending on the market in which it is placed.

Read Article

AI & Digital Health

AI Validation Requirements for FDA Submissions: What Companies Must Know Now!!

May 11, 2024
|
By Dr. Ebot Eyong

AI is reshaping medical devices, but regulatory hurdles remain. Validation is vital for FDA approval, especially with the complexities of machine learning. This article outlines key requirements including data quality, performance testing, clinical validation, transparency, risk management, lifecycle management, and real-world monitoring.

Read Article